Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens

NCT: NCT06479148 · TERMINATED

NCT IDNCT06479148
StatusTERMINATED
Start Date2024-08-15
Completion2024-12-12

Brief Summary

A Prospective, Single-Center, Randomized Clinical Investigation to evaluate the safety and performance of the enVista® Aspire ™ (EA) intraocular lens (IOL) when compared to the MX60E monofocal IOL (control lens) and an IOL with a slightly extended depth of focus (active comparator lens) for potentially improved optical properties.

Frequently Asked Questions

What is Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens?

Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens is a clinical trial registered under NCT06479148. Current status: TERMINATED.

What is the status of NCT06479148?

The current status of NCT06479148 (Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens) is: TERMINATED.

When did Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens start?

Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens started on 2024-08-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑